Profil
Dr. Kawato is an EVP and General Manager at Fujitsu Laboratories of America and is responsible for Fujitsu's advanced IT research activities as well as strategic alliances and business development in the U.S.
Previously, Dr. Kawato was a director of Fujitsu Laboratories Ltd (Japan) and directed various R&D projects, including database, artificial intelligence, software engineering and VLSI-CAD.
Anciens postes connus de Nobuaki Kawato
| Sociétés | Poste | Fin |
|---|---|---|
Diamondhead Ventures
Diamondhead Ventures Investment ManagersFinance Diamondhead Ventures focuses on investments in early-stage technology companies that are developing disruptive technologies and have strong, defensible intellectual property. The firm focuses on technology opportunities related to information security, enterprise 2.0 and cross-discipline areas, such as computational biology. Diamondhead Ventures is particularly interested in identifying investment opportunities arising from leading research universities. The firm seeks spin-out opportunities that offer significant capital efficiency benefits by leveraging prior research and development efforts and that allow the firm to fund emerging technologies at a lower risk and a lower cost than typical early-stage opportunities. Diamondhead Ventures makes initial seed and Series A investments ranging from $500,000 to $5 million. They will invest in a company prior to the full development of the technology and/or management team. | Corporate Officer/Principal | 31/12/2006 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Diamondhead Ventures
Diamondhead Ventures Investment ManagersFinance Diamondhead Ventures focuses on investments in early-stage technology companies that are developing disruptive technologies and have strong, defensible intellectual property. The firm focuses on technology opportunities related to information security, enterprise 2.0 and cross-discipline areas, such as computational biology. Diamondhead Ventures is particularly interested in identifying investment opportunities arising from leading research universities. The firm seeks spin-out opportunities that offer significant capital efficiency benefits by leveraging prior research and development efforts and that allow the firm to fund emerging technologies at a lower risk and a lower cost than typical early-stage opportunities. Diamondhead Ventures makes initial seed and Series A investments ranging from $500,000 to $5 million. They will invest in a company prior to the full development of the technology and/or management team. | Finance |
















